Industry News

Industry News

How Obesity Affects Cancer Screening

Jan 11, 2012

Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women... Read More

How Obesity Affects Cancer Screening

Jan 11, 2012

Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women... Read More

Sharing Breast Cancer Results With Children Is Popular

Jan 10, 2012

An investigation published online in CANCER, a peer-reviewed journal of the American Cancer Society has discovered that many parents share their breast cancer test results with their children, even if they are very young. Furthermore, the researchers discovered that the majority of parents believe that their children are not distressed when they find out about the test results... Read More

PSA Screening Does Not Help Mortality

Jan 10, 2012

A study published in the Journal of the National Cancer Institute reveals that there is no difference in mortality rates between men participating in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial, and men who receive usual care after 13 years follow-up. In November 1993, the multi-center, two-arm, PLCO Trial, began enrollment with follow-up, through December 2009... Read More

Following Genetic Testing For Breast Cancer Genes, Most Parents Share Results With Their Children

Jan 10, 2012

A new study has found that when parents get tested for breast cancer genes, many of them share their results with their children, even with those who are very young. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that most parents think that their children are not distressed when they learn about the test results... Read More

Circulating Tumor Cells Analyzed In Patients With Lung Cancer

Jan 10, 2012

Researchers have developed a method to analyze circulating tumor cells in the blood of patients with non-small cell lung cancer. This method, which can analyze a sample size as small as three cells, may allow clinicians to track cancer progress and treatments and could help them develop new therapies... Read More

News From The Journal Of Clinical Investigation: Jan. 9, 2012

Jan 10, 2012

ONCOLOGY: KRAS provides maintenance for pancreatic cancer The outlook for individuals diagnosed with the most common form of pancreatic cancer, pancreatic ductal adenocarcinoma (PDA), is very poor; the average time of survival after diagnosis is less than 6 months. New therapeutic approaches are therefore much needed... Read More

Sorafenib Effective In Patients With Non-small Cell Lung Cancer, But Low Survival Rates Reported

Jan 10, 2012

Sorafenib was effective in patients with non-small cell lung cancer and a KRAS mutation, but survival rates were reportedly "unsatisfactory," according to data presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine, held Jan. 8-11, 2012... Read More

Genetic Composition Of Multicentric Lung Tumors Appears To Be Similar

Jan 10, 2012

Multicentric carcinogenesis with the same genetic mutation appears to occur in lung adenocarcinoma, according to data presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine, held Jan. 8-11, 2012... Read More

Potential Genetic Origins, Pathways Of Lung Cancer In Never-Smokers, Mapped By Researchers

Jan 10, 2012

Researchers have begun to identify which mutations and pathway changes lead to lung cancer in never-smokers - a first step in developing potential therapeutic targets. Never-smokers (defined as an individual who smoked fewer than 100 cigarettes in his or her lifetime) are estimated to account for 10 percent of lung cancer cases... Read More

Previous Page   Next Page